|
Indications And Usage Nefazodone Hydrochloride Tablets Are Indicated For The Treatment Of Depression. When Deciding Among The Alternative Treatments Available For This Condition, The Prescriber Should Consider The Risk Of Hepatic Failure Associated With Nefazodone Hydrochloride Treatment (see Warnings ). In Many Cases, This Would Lead To The Conclusion That Other Drugs Should Be Tried First. The Efficacy Of Nefazodone In The Treatment Of Depression Was Established In 6 To 8 Week Controlled Trials Of Outpatients And In A 6 Week Controlled Trial Of Depressed Inpatients Whose Diagnoses Corresponded Most Closely To The Dsm-Iii Or Dsm-Iiir Category Of Major Depressive Disorder (see Clinical Pharmacology ). A Major Depressive Episode Implies A Prominent And Relatively Persistent Depressed Or Dysphoric Mood That Usually Interferes With Daily Functioning (nearly Every Day For At Least 2 Weeks). It Must Include Either Depressed Mood Or Loss Of Interest Or Pleasure And At Least Five Of The Following Nine Symptoms: Depressed Mood, Loss Of Interest In Usual Activities, Significant Change In Weight And/or Appetite, Insomnia Or Hypersomnia, Psychomotor Agitation Or Retardation, Increased Fatigue, Feelings Of Guilt Or Worthlessness, Slowed Thinking Or Impaired Concentration, A Suicide Attempt Or Suicidal Ideation. The Efficacy Of Nefazodone In Reducing Relapse In Patients With Major Depression Who Were Judged To Have Had A Satisfactory Clinical Response To 16 Weeks Of Open-Label Nefazodone Treatment For An Acute Depressive Episode Has Been Demonstrated In A Randomized Placebo-Controlled Trial (see Clinical Pharmacology ). Although Remitted Patients Were Followed For As Long As 36 Weeks In The Study Cited (i.e., 52 Weeks Total), The Physician Who Elects To Use Nefazodone For Extended Periods Should Periodically Reevaluate The Long-Term Usefulness Of The Drug For The Individual Patient.
|